Hi Tech Pharmacal Co. Inc.
369 Bayview Avenue
Amityville,
NY 11701
United States - Map
Phone: 631-789-8228
Fax: 631-789-8429
Web Site: http://www.hitechpharm.com
| Hi-Tech Pharmacal Co., Inc. develops, manufactures, markets, and sells generic, prescription, over-the-counter (OTC), and nutritional products in liquid and semisolid dosage forms in the United States. It produces a range of products for various disease states, including asthma, bronchial disorders, dermatological disorders, allergies, pain, stomach, oral care, neurological disorders, glaucoma, and other conditions. The companys generic pharmaceutical products include oral solutions and suspensions, topical creams and ointments, and nasal sprays. Hi-Tech Pharmacal Co. also manufactures and sells liquid ophthalmic, otic, and inhalation products, as well as cough and cold products and prescription vitamins. It markets a line of branded products that include OTC, nutritional lines, and prescription products primarily for people with diabetes. The companys product line comprises Diabetic Tussin for the treatment of cough; Zostrix for pain relief; DiabetiDerm, a dermatological and footcare product line; Multibetic, a multivitamin product; DiabetiSweet, a sugar substitute; and Nasal Ease for allergy relief. It offers its products to chain drug stores, drug wholesalers, managed care purchasing organizations, certain Federal government agencies, generic distributors, mass merchandisers, and mail-order pharmacies. The company was founded in 1982 and is based in Amityville, New York. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. David S. Seltzer , 49
Chairman, Chief Exec. Officer, Pres, Sec. and Treasurer |
$
442.00K |
$
519.00K | Mr. William Peters , 41
Chief Financial Officer and VP of Fin. |
$
296.00K |
$
0 | Mr. Gary M. April , 52
Pres of Health Care Products Division and Divisional VP of Sales |
$
223.00K |
$
0 | Mr. Bryce M. Harvey , 53
Pres of Midlothian Laboritories |
$
376.00K |
$
0 | Mr. Reuben Seltzer , 52
Consultant |
$
8.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
2.03% Nasdaq 0.00%
Profile
